TR201723035A2 - Dexketoprofen delayed release composition. - Google Patents

Dexketoprofen delayed release composition. Download PDF

Info

Publication number
TR201723035A2
TR201723035A2 TR2017/23035A TR201723035A TR201723035A2 TR 201723035 A2 TR201723035 A2 TR 201723035A2 TR 2017/23035 A TR2017/23035 A TR 2017/23035A TR 201723035 A TR201723035 A TR 201723035A TR 201723035 A2 TR201723035 A2 TR 201723035A2
Authority
TR
Turkey
Prior art keywords
dexketoprofen
delayed release
release composition
myalgia
toothache
Prior art date
Application number
TR2017/23035A
Other languages
Turkish (tr)
Inventor
Bi̇lgi̇ç Mahmut
Original Assignee
Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi filed Critical Neutec Ar Ge Sanayi Ve Ticaret Anonim Sirketi
Priority to TR2017/23035A priority Critical patent/TR201723035A2/en
Priority to TR2018/15617A priority patent/TR201815617A2/en
Priority to PCT/TR2018/000136 priority patent/WO2020022976A2/en
Priority to PCT/TR2018/000129 priority patent/WO2019212426A2/en
Publication of TR201723035A2 publication Critical patent/TR201723035A2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Mevcut buluş ateş, hafif ve orta şiddette ağrı, baş ağrısı, diş ağrısı, migren profilaksisi, miyalji hastalıklarının tedavisinde kullanılacak deksketoprofen serbest bazı ve deksketoprofen trometamol içeren farmasötik bileşimlere ilişkindir.The present invention relates to pharmaceutical compositions containing dexketoprofen free base and dexketoprofen trometamol for use in the treatment of fever, mild to moderate pain, headache, toothache, migraine prophylaxis, myalgia.

TR2017/23035A 2017-12-29 2017-12-29 Dexketoprofen delayed release composition. TR201723035A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
TR2017/23035A TR201723035A2 (en) 2017-12-29 2017-12-29 Dexketoprofen delayed release composition.
TR2018/15617A TR201815617A2 (en) 2017-12-29 2018-10-19 A formulation containing dexketoprofen.
PCT/TR2018/000136 WO2020022976A2 (en) 2017-12-29 2018-12-28 A formulation comprising dexketoprofen
PCT/TR2018/000129 WO2019212426A2 (en) 2017-12-29 2018-12-28 Delayed release dexketoprofen composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TR2017/23035A TR201723035A2 (en) 2017-12-29 2017-12-29 Dexketoprofen delayed release composition.

Publications (1)

Publication Number Publication Date
TR201723035A2 true TR201723035A2 (en) 2019-07-22

Family

ID=67900930

Family Applications (2)

Application Number Title Priority Date Filing Date
TR2017/23035A TR201723035A2 (en) 2017-12-29 2017-12-29 Dexketoprofen delayed release composition.
TR2018/15617A TR201815617A2 (en) 2017-12-29 2018-10-19 A formulation containing dexketoprofen.

Family Applications After (1)

Application Number Title Priority Date Filing Date
TR2018/15617A TR201815617A2 (en) 2017-12-29 2018-10-19 A formulation containing dexketoprofen.

Country Status (2)

Country Link
TR (2) TR201723035A2 (en)
WO (2) WO2019212426A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN115607509B (en) * 2022-10-11 2024-01-30 南京正科医药股份有限公司 Dexketoprofen tromethamine injection and preparation process thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101623280A (en) * 2008-07-10 2010-01-13 广东肇庆星湖生物科技股份有限公司 Compound sustained release preparation for easing pain and preparation method thereof
TR201104864A2 (en) * 2011-05-18 2012-12-21 Bi̇lgi̇ç Mahmut Water-soluble formulations containing dexketoprofen.
CN102813638A (en) * 2011-06-07 2012-12-12 贵阳医学院 Preparation method of dexketoprofen trometamol double-layer sustained-release tablets
ES2394888B1 (en) * 2011-06-15 2013-09-23 Farmalider, S.A. PHARMACEUTICAL FORM OF MODIFIED RELEASE OF DEXKETOPROPHENE AND INHIBITOR OF THE PUMP OF PROTONS AND USE OF THE SAME.
WO2013022410A2 (en) * 2011-08-08 2013-02-14 Mahmut Bilgic Production method for effervescent formulations comprising dexketoprofen
WO2013095315A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Formulations comprising dexketoprofen (particle size 300-2500 micrometer)

Also Published As

Publication number Publication date
WO2019212426A2 (en) 2019-11-07
WO2019212426A3 (en) 2019-11-28
WO2020022976A3 (en) 2020-03-12
TR201815617A2 (en) 2019-07-22
WO2020022976A2 (en) 2020-01-30

Similar Documents

Publication Publication Date Title
CR20200544A (en) Mcl-1 inhibitors
ZA201906822B (en) Indole ahr inhibitors and uses thereof
JOP20220245A1 (en) Antibodies specifically binding to masp-3 for the treatment of various diseases and disorders
MX2020001598A (en) Selective inhibitors of protein arginine methyltransferase 5 (prmt5).
MX2015011898A (en) Pyrazolo compounds and uses thereof.
EA201890161A1 (en) THERAPEUTIC COMPOSITIONS, COMBINATIONS AND APPLICATION METHODS
PH12017501669A1 (en) Alpha-cinnamide compounds and compositions as hdac8 inhibitors
MX2017001279A (en) Flagellin compositons and uses.
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
EA201991799A1 (en) DISPERSABLE IN WATER COMPOSITIONS
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
NZ732402A (en) Nitrification inhibitor compositions and methods for preparing the same
TR201901348T4 (en) Pyrrolidinone derivatives as metap-2 inhibitors.
MX2020001885A (en) Daptomycin formulations.
MX2020005841A (en) 1,2,4-oxadiazole derivatives as histone deacetylase 6 inhibitors.
MX2018005004A (en) Substituted indazole compounds as rorgammat inhibitors and uses thereof.
MY191337A (en) Compositions for the treatment of hypertension and/or fibrosis
EA202191515A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING APIXABAN
MX2018014790A (en) Combination formulation of three antiviral compounds.
TR201723035A2 (en) Dexketoprofen delayed release composition.
MX2019014192A (en) Cancer-associated immunosuppression inhibitor.
MX2019009293A (en) Compounds, compositions and uses thereof for improvement of bone disorders.
PH12016501448B1 (en) Antifungal composition
MY182809A (en) Compositions for the treatment of kidney and/or liver disease
EA201991746A1 (en) PYRAZOLE DERIVATIVES AS BROMODOMENE INHIBITORS